Niklas Hedberg

Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment

Björn Wettermark, Brian Godman, Martin Neovius et al. · Health Policy · 2009 · 74 citations

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +16

How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice

Giovanni Tafuri, Margherita Pagnini, Jane Moseley et al. · British Journal of Clinical Pharmacology · 2016 · 64 citations · Full text

Public Affairs, Health Policy, Pharmaceutical Policy +14

The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations

Giovanni Tafuri, Inês Lucas, Steve Estevão et al. · British Journal of Clinical Pharmacology · 2018 · 38 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +13

CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research

Dipak Kotecha, Folkert W. Asselbergs, Stephan Achenbach et al. · European Heart Journal · 2022 · 36 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines

Pia Frisk, Tor-Olov Mellgren, Niklas Hedberg et al. · European Journal of Clinical Pharmacology · 2008 · 25 citations

Pharmacy, Cardiology, Pharmacotherapy +16